For this year Moderna Inc 's (located in Cambridge) revenue will be around 17.43 billion USD. This is according to the average of the analysts' estimates. This is hugely lower than 2020's revenue of 803.4 million USD.
The analysts expect for 2021 a net profit of 9.45 billion USD. Most of the analysts anticipate on a profit per share of 23.29 USD. The price/earnings-ratio is then 7.28.
For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a relatively high 1.97 percent.
Based on the current number of shares Moderna Inc 's market capitalization equals 57.04 billion USD. The Moderna Inc stock was the past 12 months quite unstable. Since last April the stock is even 231 percent higher. This year the stock price moved between 45 and 189 dollar.
On Wednesday, the stock closed at 169.5 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.